Zhengye Biotechnology Holding Limited (ZYBT)
NASDAQ: ZYBT · Real-Time Price · USD
0.8305
+0.0005 (0.06%)
Jun 5, 2026, 4:00 PM EDT - Market closed
ZYBT Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 50.33 | 18.6 | 15.07 | 9.75 | 6.28 |
Short-Term Investments | 1.56 | 1.43 | 1.22 | - | - |
Cash & Short-Term Investments | 51.89 | 20.04 | 16.3 | 9.75 | 6.28 |
Cash Growth | 158.98% | 22.95% | 67.22% | 55.09% | - |
Accounts Receivable | 18.49 | 85.16 | 97.38 | 133.58 | 101.7 |
Other Receivables | - | 0.74 | 2.04 | 0.67 | 0.49 |
Total Trade Receivables | 18.49 | 85.89 | 99.42 | 134.25 | 102.19 |
Inventory | 39.17 | 58.22 | 58.3 | 55.42 | 43.62 |
Other Current Assets | 27.88 | 13.42 | 15.22 | 14.89 | 12.85 |
Total Current Assets | 137.42 | 177.57 | 189.24 | 214.31 | 164.94 |
Net Property, Plant & Equipment | 237.28 | 255.16 | 263.25 | 275.23 | 246.41 |
Other Intangible Assets | 54.76 | 22.78 | 24.48 | 27.9 | 20.75 |
Other Long-Term Assets | 7.01 | 37.74 | 22.92 | 2.23 | 13.17 |
Total Assets | 436.47 | 493.25 | 499.89 | 519.67 | 445.28 |
Accounts Payable | 44.01 | 43.11 | 45.66 | 79.28 | 77.57 |
Accrued Expenses | 3.46 | 5.62 | 2.88 | 3.46 | 3.26 |
Short-Term Debt | 65.1 | 74.44 | 79.86 | 54.89 | 30 |
Current Portion of Long-Term Debt | 0.7 | 7.19 | - | - | - |
Current Portion of Leases | 0.11 | - | - | - | - |
Unearned Revenue | 4.75 | 3.49 | 3.89 | 4.6 | 4.28 |
Other Current Liabilities | 2.35 | 2.07 | 17.95 | 10 | 10.52 |
Total Current Liabilities | 120.48 | 135.91 | 150.23 | 152.23 | 125.63 |
Long-Term Debt | 8.85 | 4.8 | 9.99 | 9.99 | - |
Long-Term Leases | 0.33 | - | - | - | - |
Other Long-Term Liabilities | 0.1 | - | 0.39 | 0.59 | 0.82 |
Total Long-Term Liabilities | 9.28 | 4.8 | 10.38 | 10.58 | 0.82 |
Total Liabilities | 129.76 | 140.71 | 160.62 | 162.81 | 126.44 |
Common Stock | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
Additional Paid-in Capital | 240.75 | 203.15 | 203.15 | 203.15 | 203.15 |
Accumulated Other Comprehensive Income | 30.72 | 32.65 | 31.31 | 27.57 | 21.99 |
Retained Earnings | -21.63 | 48.15 | 38.38 | 65.77 | 42.33 |
Total Common Shareholders' Equity | 249.85 | 283.96 | 272.85 | 296.5 | 267.47 |
Minority Interest | 56.87 | 68.58 | 66.42 | 60.37 | 51.36 |
Shareholders' Equity | 306.72 | 352.54 | 339.27 | 356.87 | 318.84 |
Total Liabilities & Equity | 436.47 | 493.25 | 499.89 | 519.67 | 445.28 |
Total Debt | 75.08 | 86.43 | 89.85 | 64.88 | 30 |
Net Cash (Debt) | -23.19 | -66.4 | -73.55 | -55.13 | -23.72 |
Net Cash Per Share | -0.49 | -1.45 | -1.61 | -1.21 | -0.52 |
Book Value | 249.85 | 283.96 | 272.85 | 296.5 | 267.47 |
Book Value Per Share | 5.28 | 6.22 | 5.97 | 6.49 | 5.86 |
Tangible Book Value | 195.09 | 261.18 | 248.37 | 268.59 | 246.72 |
Tangible Book Value Per Share | 4.12 | 5.72 | 5.44 | 5.88 | 5.40 |